Chimin Health Management Co., Ltd. (603222.SS)
CNY 6.07
(-0.82%)
CNY 6.07
(-0.82%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 820.13 Million CNY | -12.72% |
| 2022 | 939.63 Million CNY | -10.55% |
| 2021 | 1.05 Billion CNY | -15.67% |
| 2020 | 1.24 Billion CNY | 23.13% |
| 2019 | 1.01 Billion CNY | -6.17% |
| 2018 | 1.07 Billion CNY | 66.75% |
| 2017 | 646.62 Million CNY | 469.79% |
| 2016 | 113.48 Million CNY | 22.0% |
| 2015 | 93.02 Million CNY | -50.65% |
| 2014 | 188.49 Million CNY | -16.32% |
| 2013 | 225.24 Million CNY | -12.73% |
| 2012 | 258.1 Million CNY | -5.2% |
| 2011 | 272.25 Million CNY | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 808.4 Million CNY | -5.39% |
| 2024 Q1 | 854.47 Million CNY | 4.19% |
| 2024 Q3 | 766.41 Million CNY | -5.19% |
| 2023 FY | 820.13 Million CNY | -12.72% |
| 2023 Q2 | 756.02 Million CNY | -7.16% |
| 2023 Q3 | 852.22 Million CNY | 12.72% |
| 2023 Q4 | 820.13 Million CNY | -3.77% |
| 2023 Q1 | 814.31 Million CNY | -13.34% |
| 2022 FY | 939.63 Million CNY | -10.55% |
| 2022 Q4 | 939.63 Million CNY | -3.52% |
| 2022 Q3 | 973.9 Million CNY | -5.29% |
| 2022 Q1 | 1.04 Billion CNY | -0.83% |
| 2022 Q2 | 1.02 Billion CNY | -1.3% |
| 2021 Q4 | 1.05 Billion CNY | -1.38% |
| 2021 FY | 1.05 Billion CNY | -15.67% |
| 2021 Q3 | 1.06 Billion CNY | -7.73% |
| 2021 Q2 | 1.15 Billion CNY | -4.04% |
| 2021 Q1 | 1.2 Billion CNY | -3.42% |
| 2020 Q2 | 1.06 Billion CNY | 5.25% |
| 2020 Q3 | 1.09 Billion CNY | 3.24% |
| 2020 FY | 1.24 Billion CNY | 23.13% |
| 2020 Q4 | 1.24 Billion CNY | 13.46% |
| 2020 Q1 | 1.01 Billion CNY | -0.12% |
| 2019 Q1 | 1.09 Billion CNY | 1.44% |
| 2019 Q4 | 1.01 Billion CNY | -1.81% |
| 2019 Q3 | 1.03 Billion CNY | -3.09% |
| 2019 Q2 | 1.06 Billion CNY | -2.79% |
| 2019 FY | 1.01 Billion CNY | -6.17% |
| 2018 Q4 | 1.07 Billion CNY | 14.6% |
| 2018 Q3 | 940.88 Million CNY | 0.87% |
| 2018 Q2 | 932.75 Million CNY | 48.65% |
| 2018 Q1 | 627.48 Million CNY | -2.96% |
| 2018 FY | 1.07 Billion CNY | 66.75% |
| 2017 Q4 | 646.62 Million CNY | 47.44% |
| 2017 FY | 646.62 Million CNY | 469.79% |
| 2017 Q3 | 438.57 Million CNY | 2.49% |
| 2017 Q2 | 427.92 Million CNY | 14.85% |
| 2017 Q1 | 372.59 Million CNY | 228.32% |
| 2016 FY | 113.48 Million CNY | 22.0% |
| 2016 Q4 | 113.48 Million CNY | 6.38% |
| 2016 Q3 | 106.68 Million CNY | 24.9% |
| 2016 Q2 | 85.41 Million CNY | 4.07% |
| 2016 Q1 | 82.07 Million CNY | -11.77% |
| 2015 Q3 | 84.29 Million CNY | 0.71% |
| 2015 Q4 | 93.02 Million CNY | 10.35% |
| 2015 Q2 | 83.7 Million CNY | 4.46% |
| 2015 Q1 | 80.12 Million CNY | -57.49% |
| 2015 FY | 93.02 Million CNY | -50.65% |
| 2014 Q3 | 162 Million CNY | 0.0% |
| 2014 FY | 188.49 Million CNY | -16.32% |
| 2014 Q1 | - CNY | 0.0% |
| 2014 Q4 | 188.49 Million CNY | 16.35% |
| 2013 FY | 225.24 Million CNY | -12.73% |
| 2012 FY | 258.1 Million CNY | -5.2% |
| 2011 FY | 272.25 Million CNY | 0.0% |